Humana vs Careplus Berhad

Humana and Careplus Berhad are both prominent players in the healthcare industry, with a focus on providing medical insurance and healthcare services. Humana is a leading health insurance provider in the United States, known for its comprehensive coverage options and customer-centric approach. Careplus Berhad, on the other hand, is a healthcare company based in Malaysia, offering a range of pharmaceutical and medical supply products. Both companies operate in a competitive market, and their stocks are closely monitored by investors seeking opportunities in the healthcare sector.

Humana or Careplus Berhad?

When comparing Humana and Careplus Berhad, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Humana and Careplus Berhad.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Humana has a dividend yield of 1.37%, while Careplus Berhad has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Humana reports a 5-year dividend growth of 12.10% year and a payout ratio of 25.48%. On the other hand, Careplus Berhad reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Humana P/E ratio at 18.13 and Careplus Berhad's P/E ratio at -6.21. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Humana P/B ratio is 1.86 while Careplus Berhad's P/B ratio is 0.58.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Humana has seen a 5-year revenue growth of 1.07%, while Careplus Berhad's is -0.81%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Humana's ROE at 10.37% and Careplus Berhad's ROE at -9.83%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $251.24 for Humana and RM0.26 for Careplus Berhad. Over the past year, Humana's prices ranged from $213.31 to $530.54, with a yearly change of 148.72%. Careplus Berhad's prices fluctuated between RM0.25 and RM0.51, with a yearly change of 104.00%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.